Revenue
$12.11B
Fiscal year ended 2025-10-26Operating income
$718.60M
Fiscal year ended 2025-10-26Free cash flow
$534.35M
Fiscal year ended 2025-10-26HORMEL FOODS CORP /DE/ (HRL) reported revenue of $12.11B and net income of $478.20M for the fiscal year ended 2025-10-26. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from HORMEL FOODS CORP /DE/’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2025-10-26 | 2024-10-27 | 2023-10-29 | 2022-10-30 | 2021-10-31 | 2020-10-25 | 2019-10-27 | 2018-10-28 | 2017-10-29 | 2016-10-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.11B | $11.92B | $12.11B | $12.46B | $11.39B | $9.61B | $9.50B | $9.55B | $9.17B | $9.52B |
| Cost of revenue | $10.21B | $9.90B | $10.11B | $10.29B | $9.46B | $7.78B | $7.61B | $7.57B | $7.17B | $7.37B |
| Gross profit | $1.89B | $2.02B | $2.00B | $2.16B | $1.93B | $1.83B | $1.88B | $1.98B | $2.00B | $2.16B |
| Operating income | $718.60M | $1.07B | $1.07B | $1.31B | $1.12B | $1.10B | $1.20B | $1.18B | $1.28B | $1.32B |
| Net income | $478.20M | $805.04M | $793.57M | $999.99M | $908.84M | $908.08M | $978.81M | $1.01B | $846.74M | $890.05M |
| Research & development | $35.20M | $36.10M | $33.70M | $34.70M | $33.60M | $31.90M | $32.50M | $33.80M | $34.20M | $34.70M |
| Weighted-average diluted shares | shares 550.50M | shares 548.83M | shares 548.98M | shares 549.57M | shares 547.58M | shares 546.59M | shares 545.23M | shares 543.87M | shares 539.12M | shares 542.47M |
| Pretax income | $663.45M | $1.04B | $1.01B | $1.28B | $1.13B | $1.11B | $1.21B | $1.18B | $1.28B | $1.32B |
| Income tax expense | $185.68M | $230.80M | $220.55M | $277.88M | $217.03M | $206.39M | $230.57M | $168.70M | $431.54M | $426.70M |
| Diluted EPS | $0.87 | $1.47 | $1.45 | $1.82 | $1.66 | $1.66 | $1.80 | $1.86 | $1.57 | $1.64 |
| Selling, general & administrative | $996.62M | $1.01B | $942.17M | $879.26M | $853.07M | $761.32M | $727.58M | $841.20M | $759.30M | $871.97M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-10-26 | 2024-10-27 | 2023-10-29 | 2022-10-30 | 2021-10-31 | 2020-10-25 | 2019-10-27 | 2018-10-28 | 2017-10-29 | 2016-10-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $670.68M | $741.88M | $736.53M | $982.11M | $613.53M | $1.71B | $672.90M | $459.14M | $444.12M | $415.14M |
| Total assets | $13.39B | $13.43B | $13.45B | $13.31B | $12.70B | $9.91B | $8.11B | $8.14B | $6.98B | $6.98B |
| Current assets | $3.41B | $3.25B | $3.30B | $3.64B | $2.95B | $3.58B | $2.36B | $2.05B | $2.03B | $2.03B |
| Total liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current liabilities | $1.38B | $1.40B | $2.31B | $1.47B | $1.42B | $1.50B | $1.11B | $1.14B | $1.06B | $1.05B |
| Total equity incl. NCI | $7.92B | $8.00B | $7.74B | $7.54B | $6.98B | $6.43B | $5.93B | $5.60B | $4.94B | $4.45B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $1.75B | $1.58B | $1.68B | $1.72B | $1.37B | $1.07B | $1.04B | $963.53M | $921.02M | $985.68M |
| Accounts receivable | $784.81M | $817.91M | $817.39M | $867.59M | $895.72M | $702.42M | $574.40M | $600.44M | $618.35M | $591.31M |
| Goodwill | $4.92B | $4.92B | $4.93B | $4.93B | $4.93B | $2.61B | $2.48B | $2.71B | $2.12B | $1.83B |
| Long-term debt | $2.85B | $2.85B | $2.36B | $3.29B | $3.32B | $1.04B | $250.00M | $624.84M | $250.00M | $250.00M |
| Accounts payable | $731.58M | $735.60M | $771.40M | $816.60M | $793.31M | $644.61M | $590.03M | $618.83M | $552.71M | $481.83M |
Cash flow
| Metric | 2025-10-26 | 2024-10-27 | 2023-10-29 | 2022-10-30 | 2021-10-31 | 2020-10-25 | 2019-10-27 | 2018-10-28 | 2017-10-29 | 2016-10-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $845.25M | $1.27B | $1.05B | $1.13B | $1.00B | $1.13B | $923.00M | $1.24B | $1.03B | $1.04B |
| Capital expenditures | $310.90M | $256.44M | $270.21M | $278.92M | $232.42M | $367.50M | $293.84M | $389.61M | $221.29M | $255.52M |
| Investing cash flow | -$298.59M | -$236.91M | -$689.54M | -$258.04M | -$3.63B | -$656.32M | $220.15M | -$1.24B | -$587.18M | -$408.47M |
| Financing cash flow | -$614.00M | -$1.03B | -$600.06M | -$486.68M | $1.52B | $566.17M | -$926.24M | $11.64M | -$418.77M | -$557.30M |
| Net change in cash | -$71.20M | $5.35M | -$245.58M | $368.58M | -$1.10B | $1.04B | $213.76M | $15.01M | $28.98M | $67.90M |
| Stock-based compensation | $25.60M | $23.23M | $24.08M | $24.94M | $24.74M | $22.46M | $19.71M | $20.60M | $15.59M | $17.83M |
| Common dividends paid | $633.19M | $614.96M | $592.93M | $557.84M | $523.11M | $487.38M | $437.05M | $388.11M | $346.01M | $296.49M |
| Common share repurchases | $0 | $0 | $12.30M | $0 | $19.96M | $12.36M | $174.25M | $46.90M | $94.49M | $87.88M |
| Depreciation & amortization | $263.90M | $257.76M | $253.31M | $235.88M | $209.31M | $205.78M | $165.21M | $161.86M | $130.98M | $131.97M |
Derived
| Metric | 2025-10-26 | 2024-10-27 | 2023-10-29 | 2022-10-30 | 2021-10-31 | 2020-10-25 | 2019-10-27 | 2018-10-28 | 2017-10-29 | 2016-10-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $534.35M | $1.01B | $777.64M | $856.06M | $769.52M | $760.52M | $629.16M | $852.12M | $812.60M | $784.50M |
| Gross margin | 15.6% | 17.0% | 16.5% | 17.4% | 16.9% | 19.0% | 19.8% | 20.7% | 21.8% | 22.7% |
| Operating margin | 5.9% | 9.0% | 8.9% | 10.5% | 9.9% | 11.5% | 12.6% | 12.4% | 13.9% | 13.9% |
| FCF margin | 4.4% | 8.5% | 6.4% | 6.9% | 6.8% | 7.9% | 6.6% | 8.9% | 8.9% | 8.2% |
| SBC / revenue | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% |
| Current ratio | 2.47x | 2.32x | 1.43x | 2.47x | 2.08x | 2.38x | 2.14x | 1.80x | 1.92x | 1.93x |
| Revenue YoY growth | 1.6% | -1.6% | -2.8% | 9.4% | 18.5% | 1.2% | -0.5% | 4.1% | -3.7% | Unavailable |
| Net margin | 4.0% | 6.8% | 6.6% | 8.0% | 8.0% | 9.5% | 10.3% | 10.6% | 9.2% | 9.3% |
| R&D / revenue | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.4% | 0.4% |
| CapEx / revenue | 2.6% | 2.2% | 2.2% | 2.2% | 2.0% | 3.8% | 3.1% | 4.1% | 2.4% | 2.7% |
| Long-term debt / equity | 0.36x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 28.0% | 22.3% | 21.8% | 21.7% | 19.3% | 18.5% | 19.1% | 14.3% | 33.7% | 32.4% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HRL in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-27View SEC filing
10-Q · Filed 2026-05-28View SEC filing
10-Q · Filed 2026-02-26View SEC filing
10-K · Filed 2025-12-05View SEC filing
10-Q · Filed 2025-08-28View SEC filing
10-Q · Filed 2025-05-29View SEC filing
Companies in the same industry
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.